Known hypersensitivity to the active ingredient or any of the excipients. Clenbuterol may cause side effects such as sweating (mainly neck region), muscle tremor, tachycardia, slight hypotension or restlessness. These are typical for β-agonists and occur rarely.

Do not use in horses with known cardiac disease.

Ventipulmin antagonises the effects of prostaglandin F2α and oxytocin.

Ventipulmin is antagonised by β-adrenergic blocking agents.

If used during pregnancy, treatment must be discontinued at the expected time of delivery since uterine contractions may be abolished under its influence.

Doses up to 8 times the therapeutic dose of clenbuterol hydrochloride for a period of 90 days caused only transient side effects typical of β-agonists, which required no treatment. In cases of accidental overdose, a β-blocker (such as propranolol) may be used as antidote.

Animals must not be slaughtered for human consumption during treatment. Horses may be slaughtered for human consumption only after 28 days from the last treatment.

This product contains clenbuterol, a β-agonist. When using do not eat, drink or smoke. Take care to avoid skin contact. In case of skin contact wash affected are thoroughly. If irritation occurs/persists seek medical advice. Take care to avoid accidental eye contact. In the case of accidental eye contact, flush thoroughly with clean water and seek medical advice.

Dispose of any unused product and empty containers in accordance with guidance from your local waste regulation authority.

For animal treatment only. Keep out of the reach and sight of children.